FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company - Rosemary Rue - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-05-24 10:55:48 Medicine Gluten sensitivity Clinical medicine Health Nexvax2 Coeliac disease HLA-DQ2 Gluten challenge test Human leukocyte antigen HLA-DQ Gluten-free diet Autoimmunity		FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company Add to Reading List Source URL: www.immusant.com Download Document from Source Website File Size: 35,64 KB Share Document on Facebook

	FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company DocID: 1r0rg - View Document
	Microsoft PowerPointHaplotyping [Compatibility Mode] DocID: 1kRMD - View Document
	Haplotype Based Association Tests DocID: 1kzvF - View Document
	65 International Journal of Modern Anthropology Int. J. Mod. AnthropAvailable online at www.ata.org.tn Original Synthetic Report DocID: 17OBh - View Document
	PDF Document DocID: 17lMF - View Document